about
Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients.Increased level of serum prostaglandin-2 in early stage of esophageal squamous cell carcinoma.Circulating Oxidized Low-Density Lipoproteins and Antibodies against Oxidized Low-Density Lipoproteins as Potential Biomarkers of Colorectal Cancer.Fine-Needle Aspiration Biopsy as a Preoperative Procedure in Patients with Malignancy in Solitary and Multiple Thyroid Nodules.Tumor location determines midkine level and its association with the disease progression in colorectal cancer patients: a pilot study.Cytokines association with clinical and pathological changes in esophageal squamous cell carcinoma.Clinical and histopathological characteristics of patients with incidental and nonincidental thyroid cancer.Expression of cytokeratin-19 (CK19) in the classical subtype of papillary thyroid carcinoma: the experience of one center in the Silesian region.Nampt/PBEF/visfatin upregulation in colorectal tumors, mirrored in normal tissue and whole blood of colorectal cancer patients, is associated with metastasis, hypoxia, IL1β, and anemia.Concentration of serum interleukin-27 increase in patients with lymph node metastatic gastroesophageal cancer.Evaluation of 8-hydroxydeoxyguanosine, thiobarbituric acid-reactive substances and total antioxidant status as possible disease markers in oesophageal malignancies.[Abnormal metabolism of triglycerides fractions in chronic pancreatitis and results after the operation treatment].Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance.Oxidative DNA damage and total antioxidant status in serum of patients with esophageal squamous cell carcinoma.Diagnostics of Thyroid Malignancy and Indications for Surgery in the Elderly and Younger Counterparts: Comparison of 3,749 Patients.Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-alpha, VEGF-A, VEGF-C and midkine in gastroesophageal cancer patients.Midkine is up-regulated in both cancerous and inflamed bowel, reflecting lymph node metastasis in colorectal cancer and clinical activity of ulcerative colitis.Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors.Serum interleukin-12 and interleukin-18 levels in patients with oesophageal squamous cell carcinoma.Expression stability of common housekeeping genes is differently affected by bowel inflammation and cancer: implications for finding suitable normalizers for inflammatory bowel disease studies.Serum sulfatase activity is more elevated in colonic adenomas than cancers.Thyroid incidentaloma as a "PAIN" phenomenon- does it always require surgery?Patients with III and IV category of the Bethesda System under levothyroxine non-suppressive therapy have a lower rate of thyroid malignancy.Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC)Impact of systemic hypoxemia on cancer aggressiveness and circulating vascular endothelial growth factors A and C in gastroesophageal cancer patients with chronic respiratory insufficiencyElevation of circulating interleukin-8 is related to lymph node and distant metastases in esophageal squamous cell carcinomas--implication for clinical evaluation of cancer patientSerum midkine depends on lymph node involvement and correlates with circulating VEGF-C in oesophageal squamous cell carcinomaAcute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancersRespiratory insufficiency related to COPD accelerates systemic inflammation, under-nutrition, and angiogenesis in esophageal malignanciesCirculating leptin and inflammatory response in esophageal cancer, esophageal cancer-related cachexia-anorexia syndrome (CAS) and non-malignant CAS of the alimentary tractIncrease in serum platelet-derived growth factor (PDGF)-BB reflects lymph node involvement in esophageal cancer patients independently from platelet countIncreased content of resistin in epicardial adipose tissue of patients with advanced coronary atherosclerosis and history of myocardial infarctionToll-like receptors TLR-2, TLR-4, TLR-7, and TLR-9 in tumor tissue and serum of the patients with esophageal squamous cell carcinoma and gastro-esophageal junction cancerEvaluation of Apelin and Apelin Receptor Level in the Primary Tumor and Serum of Colorectal Cancer PatientsEvaluation of selected ultrasound features of thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance for the Bethesda reporting system for thyroid cytologyAssessment of apelin, apelin receptor, resistin, and adiponectin levels in the primary tumor and serum of patients with esophageal squamous cell carcinomaSitagliptin-Dependent Differences in the Intensity of Oxidative Stress in Rat Livers Subjected to Ischemia and ReperfusionThe occurrence of and predictive factors for multifocality and bilaterality in patients with papillary thyroid microcarcinomaLocal and Systemic IL-7 Concentration in Gastrointestinal-Tract Cancers
P50
Q33890823-B19848C4-50F7-4771-BC1F-2E1C92ED65CAQ34466680-D579D268-8D46-48BB-BC91-1C5F6B096228Q35412584-51C44D93-0454-45FA-9DC7-47DEA4E0C683Q35897597-78C03975-B6F6-4BC6-84AB-B4B81A84B0E5Q36253359-1B2B7AF0-E9C1-49F8-BE7F-42104438F285Q37424186-DC2637BC-5A5C-4E49-92C6-0AAD3C3E8036Q37675529-6AC617A7-96DE-40FE-BF28-C4228F7859EFQ39041409-D35ABEBC-52BD-4C44-86D4-F38AA7D7C9F4Q41107652-47373EF3-29F9-4CAB-939A-64591C7CC130Q45008806-A17EA765-5F13-4375-94FA-6C720F38FB84Q46629371-CCF4705F-1597-4F7B-9468-560C7D70B0D6Q46671045-8907D998-BDDE-459F-97D7-7B509CDF7E46Q46872520-4C09CA64-599F-46CB-B70C-84692760FCDDQ46895376-7AF673B8-CA0C-44DF-8ECF-85E1D1D2F3A4Q46972627-FFB83AF7-0FAB-4366-8733-0BB6798C98FEQ47266199-33E330A9-97EB-4433-8466-92D85BB955FDQ51443528-2C0D4B8E-1811-438F-A874-13C31F1E2D7CQ51758358-7FA17888-12A6-47A4-921E-9D9743D0C833Q51767606-F63EFDC5-959B-4EC1-8519-F2DD27F60341Q53236996-6DCD2D3B-F6B9-40E8-9484-D2564472E53AQ53325151-2E599789-EDC5-446F-9D12-2964D0F67976Q60961836-5C519E00-D67C-4490-9838-9429A41CDB33Q64917204-C8665A3D-82F6-436E-878F-8C4E9D9355B0Q64986393-2F99BA4A-99F2-4798-AF8A-98382316177DQ79163032-AD729D42-DB47-4BCE-8941-82E40D9895D9Q79837048-6824A39A-A1EC-4294-A091-EAC129370BB0Q80464919-D4073188-8E81-4561-A67C-07DC05A4EC52Q80469391-36E35579-EA25-43A9-A004-5FEB6976978EQ80783548-50617B4D-EDB0-468D-8D1A-12DA63EBB1A1Q81156994-162E0C00-D6EF-4058-AE91-120973BB114AQ84391685-69B68070-6CF2-4858-88F1-DF5C156DB3B2Q85009557-4BA7F722-40F7-4B20-90EC-F4828C61CD89Q87980661-06292C87-F5B7-4675-BAEC-444E14F54987Q89398627-C2A7AB33-4748-45D4-AFE2-5A15E4B8B427Q90228196-5DD1F0AF-A11D-41EB-9FFA-5080097EE663Q90826878-4E22A623-C853-47F1-A2C8-FCBE772554EDQ91034359-FEE9F059-A320-4DE8-974E-8FC0318CA93BQ91531336-4776296D-3C93-4571-970F-249AC99DB648Q91979859-C1411A6E-8F98-44A3-B10E-3A624503E43DQ92661775-7261A0B8-F4C3-4D08-8D06-F2CB522D1B31
P50
description
researcher ORCID ID = 0000-0002-1377-5601
@en
wetenschapper
@nl
name
Dorota Diakowska
@ast
Dorota Diakowska
@en
Dorota Diakowska
@es
Dorota Diakowska
@nl
type
label
Dorota Diakowska
@ast
Dorota Diakowska
@en
Dorota Diakowska
@es
Dorota Diakowska
@nl
prefLabel
Dorota Diakowska
@ast
Dorota Diakowska
@en
Dorota Diakowska
@es
Dorota Diakowska
@nl
P106
P214
45147266554935480201
P31
P496
0000-0002-1377-5601
P7859
viaf-45147266554935480201